Roche uses Recursion AI to uncover new brain disease targets
Roche is partnering with Recursion to use its AI platform to uncover new therapeutic targets for brain diseases. The tie-up reflects the pitch of a new generation of AI biotechs betting that computational discovery can reduce the number of failed drug trials.
1 source
Daily brief
Get tomorrow's AI brief in your inbox
More stories today
- Explyt beats Cursor on grpc-java debugging task
- Million-line inference harnesses are neurosymbolic architectures: Chollet
- UAE Fund Weighs $6.3 Billion AI Data Center Investment in Japan
- Midjourney 'MJ-Odyssey' concept art imagines The Odyssey
- No Priors podcast discusses AI startup dynamics and founder ambition